Collectively, these findings support and extend prior work by Milanski and colleagues that implicated TLR4 in obesity-induced glial activation in hypothalamus, which may contribute to systemic metabolic disturbances [54, 55]. The gene discussed is TLR4; the disease is obesity due to melanocortin 4 receptor deficiency.